P.2.c.006 Efficacy and safety of bupropion extended release in elderly patients with major depressive disorder

European Neuropsychopharmacology ◽

10.1016/s0924-977x(06)70340-6 ◽

2006 ◽

Vol 16 ◽

pp. S315-S316 ◽

Author(s):

W. Chrzanowski ◽

R. Rousseau ◽

K. Hewett ◽

M.D. Gee ◽

D. Wightman ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Extended Release ◽

Efficacy And Safety ◽

Major Depressive

Download Full-text

Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/yic.0000000000000007 ◽

2014 ◽

Vol 29 (2) ◽

pp. 93-105 ◽

Author(s):

Stuart A. Montgomery ◽

A. Carlo Altamura ◽

Heikki Katila ◽

Catherine Datto ◽

Johan Szamosi ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Extended Release ◽

Major Depressive ◽

Quetiapine Fumarate

Download Full-text

A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/yic.0000000000000304 ◽

2020 ◽

Vol 35 (3) ◽

pp. 137-146 ◽

Author(s):

Andrea Fagiolini ◽

Umberto Albert ◽

Laura Ferrando ◽

Erik Herman ◽

Cosmina Muntean ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Extended Release ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Major Depressive ◽

Download Full-text

Efficacy and safety of multiple doses of levomilnacipran extended-release for the treatment of major depressive disorder

Neuropsychiatric Disease and Treatment ◽

10.2147/ndt.s114955 ◽

2016 ◽

Vol Volume 12 ◽

pp. 2707-2714 ◽

Author(s):

Qunlian Huang ◽

Xiaoyan Zhong ◽

Yun Ye ◽

Bin Yu ◽

Yilan Huang

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Extended Release ◽

Efficacy And Safety ◽

Major Depressive ◽

Download Full-text

Randomized, Double-Blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Elderly Patients With Major Depressive Disorder

American Journal of Geriatric Psychiatry ◽

10.1097/jgp.0b013e3182545e50 ◽

2012 ◽

pp. 1 ◽

Author(s):

Heikki Katila ◽

Irina Mezhebovsky ◽

Amy Mulroy ◽

Lovisa Berggren ◽

Hans Eriksson ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Extended Release ◽

Blind Study ◽

Double Blind Study ◽

Major Depressive ◽

Double Blind ◽

Quetiapine Fumarate ◽

Download Full-text

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/yic.0b013e3283542457 ◽

2012 ◽

Vol 27 (4) ◽

pp. 215-223 ◽

Author(s):

Cornelius Katona ◽

Thomas Hansen ◽

Christina Kurre Olsen

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Effects of once-daily extended release quetiapine fumarate (quetiapine XR) on quality of life and sleep in elderly patients with major depressive disorder

Journal of Affective Disorders ◽

10.1016/j.jad.2013.01.021 ◽

2013 ◽

Vol 149 (1-3) ◽

pp. 189-195 ◽

Author(s):

Julie C. Locklear ◽

Henrik Svedsäter ◽

Catherine Datto ◽

Jean Endicott

Keyword(s):

Quality Of Life ◽

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Extended Release ◽

Major Depressive ◽

Quetiapine Fumarate ◽

Download Full-text

Efficacy and safety of agomelatine oral administration (25 to 50 mg/day) in elderly patients suffering from major depressive disorder: an 8-week, randomised, double-blind, flexible-dose, parallel groups, placebo-controlled, international, multicentre study followed by an extension double-blind treatment period of 16 weeks

http://isrctn.org/> ◽

10.1186/isrctn57507360 ◽

2013 ◽

Author(s):

Reinhard Heun

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Oral Administration ◽

Multicentre Study ◽

Treatment Period ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Download Full-text

Efficacy and safety of bupropion hydrochloride extended-release versus escitalopram oxalate in Chinese patients with major depressive disorder: Results from a randomized, double-blind, non-inferiority trial

Journal of Affective Disorders ◽

10.1016/j.jad.2019.07.023 ◽

2019 ◽

Vol 257 ◽

pp. 143-149 ◽

Author(s):

Yifeng Shen ◽

Qian Zhao ◽

Yimin Yu ◽

Yunlong Tan ◽

Honggeng Zhang ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Extended Release ◽

Chinese Patients ◽

Efficacy And Safety ◽

Major Depressive ◽

Download Full-text

Randomized, Double-Blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Elderly Patients with Major Depressive Disorder

American Journal of Geriatric Psychiatry ◽

10.1016/j.jagp.2013.01.010 ◽

2013 ◽

Vol 21 (8) ◽

pp. 769-784 ◽

Author(s):

Heikki Katila ◽

Irina Mezhebovsky ◽

Amy Mulroy ◽

Lovisa Berggren ◽

Hans Eriksson ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Extended Release ◽

Blind Study ◽

Double Blind Study ◽

Major Depressive ◽

Double Blind ◽

Quetiapine Fumarate ◽

Download Full-text

Network meta-analysis of the efficacy and safety of antidepressants for acutely ill elderly patients with major depressive disorder

European Neuropsychopharmacology ◽

10.1016/j.euroneuro.2018.11.632 ◽

2019 ◽

Vol 29 ◽

pp. S417

Author(s):

M. Krause ◽

S. Leucht

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Meta Analysis ◽

Efficacy And Safety ◽

Major Depressive

Download Full-text